Welcome to visit Zhongnan Medical Journal Press Series journal website!
Zhongnan Medical Journal Press
Series of Journals
Center for Evidence-Based and Translational Medicine of Wuhan University
The title
The title
The keywords
The author
Submit
Home
About us
Journal Introduction
Chief Editor
Editorial Committee
Author Center
Submission Guide
Assignment Agreement
Articles
Subscribe
Copyright
Contact us
Draft submission system
Author login
Author register
Reviewer login
Editor login
Home
Results
The title
The title
The keywords
The author
A total of
2
result was found. Results that relate to
Sorafenib
替雷利珠单抗较索拉非尼作为晚期不可切除肝细胞癌一线治疗的成本-效用分析
SU Zhan
CHE Jinhui
PEI Ruifeng
DOI:10.12173/j.issn.1008-049X.202312216
Hepatocellular carcinoma
Tislelizumab
Sorafenib
Partition survival model
Pharmacoeconomic analysis
Details
Download
Mobile
替雷利珠单抗联合索拉非尼治疗不可切除肝细胞性肝癌的疗效和安全性
JIANG Jinghua
HU Yiting
DOI:10.12173/j.issn.1008-049X.202406071
Tirilizumab
Sorafenib
Unresectable
Hepatocellular carcinoma
Objective response rate
Disease control rate
Progression-free survival
Overall survival
Details
Download
Mobile